Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma

Biomaterials

Volumn 29, Issue 23, 2008, Pages 3338-3345

  Liu, Yunsong ^a   Zhou, Yongsheng ^a   Feng, Hailan ^a   Ma, Gui e ^b   Ni, Yongwei ^a  

^a PEKING UNIVERSITY   (China)

^b PLASTIC SURGERY HOSPITAL   (China)

Author keywords

Adipose derived stromal cells; Bone tissue engineering; Cell differentiation; Cell proliferation; Injectable bone; Platelet rich plasma

Indexed keywords

CELL PROLIFERATION; PATIENT MONITORING; PLASMA (HUMAN); TISSUE ENGINEERING;

ADIPOSE-DERIVED STROMAL CELLS; BONE TISSUE ENGINEERING; CELL DIFFERENTIATION; PLATELET-RICH PLASMA;

BONE;

ALKALINE PHOSPHATASE; EOSIN; HEMATOXYLIN; TETRAZOLIUM BLUE; THROMBIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE STRUCTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; STAINING; STROMA CELL; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ADIPOCYTES; ALKALINE PHOSPHATASE; ANIMALS; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MATERIALS TESTING; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, ELECTRON, SCANNING; MINERALS; OSTEOGENESIS; PLATELET-RICH PLASMA; STROMAL CELLS; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 44349171669     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.04.037     Document Type: Article

References (35)

1. Montjovent M.O., Burri N., Mark S., Federici E., Scaletta C., Zambelli P.Y., et al. Fetal bone cells for tissue engineering. Bone 35 (2004) 1323-1333
2. Yoon E., Dhar S., Chun D.E., Gharibjanian N.A., and Evans G.R.D. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 13 (2007) 619-627
3. Li H., Dai K., Tang T., Zhang X., Yan M., and Lou J. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2. Biochem Biophys Res Commun 356 (2007) 836-842
4. Anitua E., Sanchez M., Orive G., and Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28 (2007) 4551-4560
5. Anitua E., Sanchez M., Nurden A.T., Nurden P., Gorka O., and Andia I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 24 (2006) 227-234
6. Ito K., Yamada Y., Nagasaka T., Baba S., and Ueda M. Osteogenic potential of injectable tissueengineered bone: a comparison among autogenous bone, bone substitute (Bio-Oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings. J Biomed Mat Res A 73 (2005) 63-72
7. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R., et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 638-646
8. Kim E.S., Park E.J., and Choung P.H. Platelet concentration and its effect on bone formation in calvarial defects: an experimental study in rabbits. J Prosthet Dent 86 (2001) 428-433
9. Weibrich G., Kleis W.K.G., and Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 17 (2002) 184-190
10. Slavkin H.C., and Bartold P.M. Challenges and potential in tissue engineering. Periodontol 2000 41 (2006) 9-15
11. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
12. 3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro. Chin Med J (Engl) 119 (2006) 1278-1286
13. Han J., Meng H.X., Tang J.M., Li S.L., Tang Y., and Chen Z.B. The effect of different platelet-rich plasma concentrations on proliferation and differentiation of human periodontal ligament cells in vitro. Cell Prolif 40 (2007) 241-252
14. Doucet C., Ernou I., Zhang Y., Llense J.R., Begot L., Holy X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell based therapy applications. J Cell Physiol 205 (2005) 228-236
15. Lucarelli E., Beccheroni A., Donati D., Sangiorgi L., Cenacchi A., Del Vento A.M., et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24 (2003) 3095-3100
16. Cenni E., Ciapetti G., Pagani S., Perut F., Giunti A., and Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts. J Periodontol 76 (2005) 323-328
17. Weibrich G., Hansen T., Kleis W., Buch R., and Hitzler W.E. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 34 (2004) 665-671
18. Graziani F., Ivanovski S., Cei S., Ducci F., Tonetti M., and Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17 (2006) 212-219
19. Ivarsson M., McWhirter A., Borg T.K., and Rubin K. Type I collagen synthesis in cultured human fibroblasts: regulation by cell spreading, platelet-derived growth factor and interactions with collagen fibers. Matrix Biol 16 (1998) 409-425
20. Centrella M., and Canalis E. Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae. Proc Natl Acad Sci U S A 82 (1985) 7335-7339
21. Gosain A.K., Song L.S., Santoro T., Weihrauch D., Bosi B.O., Corrao M.A., et al. Effects of transforming growth factor-beta and mechanical strain on osteoblast cell counts: an in vitro model for distraction osteogenesis. Plast Reconstr Surg 105 (2000) 130-136
22. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31 (2002) 469-484
23. Fennis J.P., Stoelinga P.J., and Jansen J.A. Mandibular reconstruction: a histological and histomorphometric study on the use of autogenous scaffolds, particulate corticocancellous bone grafts and platelet rich plasma in goats. Int J Oral Maxillofac Surg 33 (2004) 48-55
24. Dugrillon A., and Kluter H. Topical application of platelets for improved wound healing. Blood Ther Med 3 (2002) 21-26
25. Wiltfang J., Kloss F.R., Kessler P., Nkenke E., Schultze-Mosgau S., Zimmermann R., et al. Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. Clin Oral Implants Res 15 (2004) 187-193
26. Robiony M., Polini F., Costa F., and Politi M. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: preliminary results. J Oral Maxillofac Surg 60 (2002) 630-635
27. Kassolis J.D., Rosen P.S., and Reynolds M.A. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol 71 (2000) 1654-1661
28. Wiltfang J., Schlegel K.A., Schultze-Mosgau S., Nkenke E., Zimmermann R., and Kessler P. Sinus floor augmentation with β-tricalcium phosphate (β-TCP): does platelet-rich plasma promote its osseous integration and degradation?. Clin Oral Implants Res 14 (2003) 213-218
29. Froum S.J., Wallace S.S., Tarnow D.P., and Cho S.C. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 22 (2002) 45-53
30. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62 (2004) 489-496
31. Barbero J.E.F., Moreno P.G., Ortiz G.A., Caba O., Fernandez E.S., and Wang H.L. Flow cytometric and morphological characterization of platelet-rich plasma gel. Clin Oral Implants Res 17 (2007) 687-693
32. Lei W., Cui G., and Hu Y.Y. Experimental investigations of the injectable osteoinductive material with fibrin sealant as a carrier in inducing ectopic boneformation of mice. Orthop J Chin 12 (2004) 765-767
33. Yamada Y., Ueda M., Naiki T., and Nagasaka T. Tissue-engineered injectable bone regeneration for osseointegrated dental implants. Clin Oral Implants Res 15 (2004) 589-597
34. Reddi A.H. Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. Tissue Eng 6 (2000) 351-359
35. Griffith L.G., and Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 295 (2002) 1009-1014